Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000150056 | SCV000112720 | pathogenic | not provided | 2017-10-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000011962 | SCV000952089 | pathogenic | Duchenne muscular dystrophy | 2024-09-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg2982*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Duchenne muscular dystrophy (PMID: 1549596, 21396098, 21515508, 23536893, 26968818, 28859693). ClinVar contains an entry for this variant (Variation ID: 11211). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000150056 | SCV002019401 | pathogenic | not provided | 2023-01-23 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV000011962 | SCV002769628 | pathogenic | Duchenne muscular dystrophy | 2022-12-16 | criteria provided, single submitter | clinical testing | PVS1, PM2, PP5 |
Athena Diagnostics | RCV000150056 | SCV004229587 | pathogenic | not provided | 2022-09-29 | criteria provided, single submitter | clinical testing | This variant is expected to result in the loss of a functional protein. This variant has been identified in multiple unrelated males with Duchenne muscular dystrophy and at least one individual with dilated cardiomyopathy. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). |
OMIM | RCV000011962 | SCV000032196 | pathogenic | Duchenne muscular dystrophy | 1992-03-15 | no assertion criteria provided | literature only | |
Natera, |
RCV001831560 | SCV002080216 | pathogenic | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-01-31 | no assertion criteria provided | clinical testing |